Insights from ELCC 2024
ELCC 2024 Insights: "Polypharmacy and Concomitant Medications as Prognostic Factors for Immune Checkpoint Blockade in NSCLC"
By
Insights from ELCC 2024
FEATURING
Alessio Cortellini
By
Insights from ELCC 2024
FEATURING
Alessio Cortellini
Comments 0
Login to view comments.
Click here to Login
